News

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

"Donald Trump Signs The Pledge" by Michael Vadon 
is licensed under CC BY-SA 2.0.

This is...

By Andrew Pollack, The New York Times | 06.06.2012

For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from...

By Sandi Doughton, The Seattle Times | 06.06.2012

Researchers at the University of Washington have assembled the first comprehensive genetic map of an unborn child — a development...

By Ewen Callaway, Nature | 06.06.2012
Condoleezza Rice, former US Secretary of State and national security adviser, ought to be a tough woman to surprise. Yet...
By Lynn Bonner, News Observer | 06.05.2012
The state House approved in an 86-31 vote Tuesday a measure that will compensate people sterilized by a state authority...
By Lynn Bonner, News Observer | 06.05.2012
The state House approved in an 86-31 vote Tuesday a measure that will compensate people sterilized by a state authority...
By Dan Bilefsky, The New York Times | 06.01.2012
BELGRADE — Pavle Mircov and his partner Daniella nervously scan their e-mail in-box every 15 minutes, desperate for economic salvation...
By Dan Bilefsky, The New York Times | 06.01.2012
BELGRADE — Pavle Mircov and his partner Daniella nervously scan their e-mail in-box every 15 minutes, desperate for economic salvation...
By Dan Vorhaus, Genomics Law Report | 06.01.2012

Earlier this week 23andMe, the Silicon Valley-based personal genomics company, was awarded its first patent: US Patent Number 8,187,811, entitled...